![Martin Windisch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Mr. Martin Windisch is Head-Drug Production & Development at Curadis GmbH.
Mr. Windisch was previously employed as a Principal by University of Gottingen and a Principal by Universitätsklinikum Erlangen.
Eerdere bekende functies van Martin Windisch
Bedrijven | Functie | Einde |
---|---|---|
University of Gottingen | Corporate Officer/Principal | 01-01-1984 |
Universitätsklinikum Erlangen | Corporate Officer/Principal | 01-01-1981 |
Curadis GmbH
![]() Curadis GmbH Medical/Nursing ServicesHealth Services Curadis GmbH develops medical treatment and diagnostic products. It specializes in medical research and development activities with focus on cancer treatment. The company was founded by Heinrich Wieland and Martin Windisch in 2008 and is headquartered in Erlangen, Germany. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Curadis GmbH
![]() Curadis GmbH Medical/Nursing ServicesHealth Services Curadis GmbH develops medical treatment and diagnostic products. It specializes in medical research and development activities with focus on cancer treatment. The company was founded by Heinrich Wieland and Martin Windisch in 2008 and is headquartered in Erlangen, Germany. | Health Services |